Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

EAF2 anticorps (AA 210-260)

Cet anticorps Lapin Polyclonal détecte spécifiquement EAF2 dans IP et IHC (fp). Il présente une réactivité envers Humain.
N° du produit ABIN7454454

Aperçu rapide pour EAF2 anticorps (AA 210-260) (ABIN7454454)

Antigène

Voir toutes EAF2 Anticorps
EAF2 (ELL Associated Factor 2 (EAF2))

Reactivité

  • 20
  • 4
  • 3
Humain

Hôte

  • 18
  • 2
Lapin

Clonalité

  • 20
Polyclonal

Conjugué

  • 16
  • 2
  • 1
  • 1
Cet anticorp EAF2 est non-conjugé

Application

  • 12
  • 9
  • 8
  • 6
  • 3
  • 2
  • 1
  • 1
  • 1
Immunoprecipitation (IP), Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections) (IHC (fp))
  • Épitope

    • 6
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 210-260

    Fonction

    Rabbit anti-EAF2 Antibody, Affinity Purified

    Purification

    Affinity Purified

    Immunogène

    between AA 210 and 260

    Isotype

    IgG
  • Indications d'application

    IHC: 1:500 - 1:2,000. Epitope retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections.

    IP: 2 - 5 μg/mg lysate

    WB: Not recommended. A302-503A has not performed satisfactorily when used for WB of EAF2 in crude preparations (e.g. whole cell lysate). This antibody can be used for WB of enriched (e.g. immunoprecipitated) sources of EAF2.

    Restrictions

    For Research Use only
  • Concentration

    1000 μg/mL

    Buffer

    Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C

    Date de péremption

    12 months
  • Antigène

    EAF2 (ELL Associated Factor 2 (EAF2))

    Autre désignation

    EAF2

    Sujet

    Background: ELL-associated factor 2 (EAF2) acts as a transcriptional transactivator of TCEA1 elongation activity. It is also a transcriptional transactivator of ELL (eleven nineteen lysine-rich leukemia) 1 and ELL2 elongation activities. EAF2 has been shown to be a potent inducer of apoptosis in prostatic and non-prostatic cell lines and to inhibit prostate tumor growth in vivo [taken from the Universal Protein Resource (UniProt) Q96CJ1].

    ID gène

    55840

    NCBI Accession

    NP_060926

    UniProt

    Q96CJ1
Vous êtes ici:
Chat with us!